Showing results (141-150 of 347) with videos related to

Sort By:
Pageof 35
Journal of Cutaneous Medicine and Surgery|January 8, 2010
Update on alefacept safetyDenise Wexler, Gordon Searles, Ian Landells, et al.
The Journal of Allergy and Clinical Immunology|March 19, 2002
Task force report: future research needs for the prevention and management of immune-mediated drug hypersensitivity reactionsN Franklin Adkinson, David Essayan, Rebecca Gruchalla, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 1, 2005
Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic reviewVincent C Tam, Sandra R Knowles, Patricia L Cornish, et al.
Clinical and Translational Gastroenterology|June 19, 2019
Novel HLA Class I Alleles Outside the Extended DR3 Haplotype Are Protective against Autoimmune HepatitisCraig Lammert, Elizabeth J McKinnon, Naga Chalasani, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 23, 2022
Drug Allergy Practice Parameter Updates to Incorporate Into Your Clinical PracticeAleena Banerji, Roland Solensky, Elizabeth J Phillips, et al.
Current Opinion in Allergy and Clinical Immunology|May 27, 2021
Role of pharmacogenomics in T-cell hypersensitivity drug reactionsRebecca J Hertzman, Pooja Deshpande, Andrew Gibson, et al.
Current Opinion in Pediatrics|August 29, 2022
Advances in immunoglobulin E mediated antibiotic allergyChristine R F Rukasin, Elizabeth J Phillips, Cosby A Stone
Journal of the American Academy of Dermatology|February 25, 2021
Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial dataNeil H Shear, Keith A Betts, Ahmed M Soliman, et al.
Epilepsia|March 7, 2014
Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactionsUrsula Amstutz, Neil H Shear, Michael J Rieder, et al.
Journal of Cutaneous Medicine and Surgery|May 4, 2005
Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004Lyn Guenther, Richard G Langley, Neil H Shear, et al.
Pageof 35